TOXOPLASMA DNA DETECTION BY PCR BLOOD

The Toxoplasma DNA Detection by PCR Blood test identifies genetic material (DNA) of Toxoplasma gondii in a peripheral blood sample using sensitive molecular amplification techniques. This PCR-based assay provides rapid and specific evidence of active or disseminated infection, complementing serology when acute infection or congenital transmission is suspected. Fast, accurate detection is important for timely treatment decisions—especially in pregnant women, neonates, and immunocompromised patients in Dubai and across the UAE.

• Toxoplasma gondii DNA (Qualitative PCR)
• Toxoplasma gondii DNA Load (Quantitative PCR — if ordered)
• PCR Internal Control (assay validity)
• Sample Type: Peripheral whole blood (EDTA)

• Suspected acute toxoplasmosis with fever, lymphadenopathy, or flu‑like illness
• Pregnant women with recent seroconversion or positive IgM to assess fetal risk
• Immunocompromised patients (HIV, transplant, oncology) with systemic or CNS symptoms
• Newborns or infants with signs suggestive of congenital toxoplasmosis
• Unexplained encephalitis or focal neurological deficits where T. gondii is in the differential

• High sensitivity and specificity for detecting active Toxoplasma infection
• Rapid molecular results that aid prompt clinical decision‑making
• At‑home sample collection across Dubai with certified laboratory processing
• Useful for monitoring treatment response when quantitative PCR is available
• Complimentary to serology to clarify acute vs. past infection

• At‑home blood collection: peripheral whole blood collected in EDTA tube
• No fasting required prior to sample collection
• Avoid initiating antiparasitic therapy before sampling when clinically feasible
• Provide relevant clinical details—pregnancy status, immune status, recent serology—to the collector